2024 - Using Prognostic AI Models in Pathology: Case Colorectal Cancer
Date2024-06-13
Deadline2024-06-13
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Biomarkers; Healthcare
Topics/Call fo Papers
Discover an informative webinar on how artificial intelligence (AI) can aid oncologists and pathologists working in the gastrointestinal field.
In this webinar, the speakers will focus on an AI model that identifies important histological features of colorectal cancer (CRC) and provides a recurrence prediction estimate that can be useful for making treatment decisions.
There is tremendous morphologic heterogeneity in colorectal carcinoma, which can be helpful for predicting prognosis, underlying molecular alterations and determining the response to specific therapies. QuantCRC, a deep learning segmentation algorithm, harnesses quantitative data from digitized hematoxylin and eosin (H&E)-stained slides to improve the prediction of tumor recurrence using the Aiforia® Platform.
The AI model identifies clinically relevant prognostic risk groups, providing a powerful adjunct to routine pathologic reporting of CRC.
By attending this webinar, the attendees will gain insights into:
Current state of CRC pathology and pathologic features that guide oncologic decision-making
How an AI-integrated risk scheme using available, inexpensive (H&E)-stained slides can improve risk assessment for cancer patients
Register for this webinar today to learn about the exciting case of AI in pathology and how prognostic AI models are revolutionizing the future of pathology image analysis.
Keywords: Oncology, Biomarkers, Digital Health, Pathology, Medical Imaging, Clinical Data, Diagnostics, Therapeutic Areas, Imaging, Laboratory Technology, AI, Digital Pathology, Pre-Clinical, Other Software
In this webinar, the speakers will focus on an AI model that identifies important histological features of colorectal cancer (CRC) and provides a recurrence prediction estimate that can be useful for making treatment decisions.
There is tremendous morphologic heterogeneity in colorectal carcinoma, which can be helpful for predicting prognosis, underlying molecular alterations and determining the response to specific therapies. QuantCRC, a deep learning segmentation algorithm, harnesses quantitative data from digitized hematoxylin and eosin (H&E)-stained slides to improve the prediction of tumor recurrence using the Aiforia® Platform.
The AI model identifies clinically relevant prognostic risk groups, providing a powerful adjunct to routine pathologic reporting of CRC.
By attending this webinar, the attendees will gain insights into:
Current state of CRC pathology and pathologic features that guide oncologic decision-making
How an AI-integrated risk scheme using available, inexpensive (H&E)-stained slides can improve risk assessment for cancer patients
Register for this webinar today to learn about the exciting case of AI in pathology and how prognostic AI models are revolutionizing the future of pathology image analysis.
Keywords: Oncology, Biomarkers, Digital Health, Pathology, Medical Imaging, Clinical Data, Diagnostics, Therapeutic Areas, Imaging, Laboratory Technology, AI, Digital Pathology, Pre-Clinical, Other Software
Other CFPs
- Advancing Alzheimer’s Clinical Trial Endpoints: Imaging Biomarkers, COA Challenges, Movement Measures, and CV Risk
- Regulatory Documentation: Navigating the Complexities of Documentation Compliance
- Unifying GxP Compliance: Digital Strategies for Biopharma Quality Systems
- Accelerating Early Phase Biologics from the Clinic to Commercialization
- Addressing the Issue of Genomic Stability in iPSCs: New Approach for Restoring Cell Lines
Last modified: 2024-06-12 05:09:36